382601-29-8

Basic information

• Product Name: 2'-(2,2,2-trichloroethoxycarbonyl)-7-[3-methyl-3-(2,4,6-trimethoxyphenylmethylsulfanyl)butyryl]paclitaxel
• Synonyms: 2'-(2,2,2-trichloroethoxycarbonyl)-7-[3-methyl-3-(2,4,6-trimethoxyphenylmethylsulfanyl)butyryl]paclitaxel
• CAS NO: 382601-29-8
• Molecular Weight: 1325.71
• Mol File: 382601-29-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2'-(2,2,2-trichloroethoxycarbonyl)-7-[3-methyl-3-(2,4,6-trimethoxyphenylmethylsulfanyl)butyryl]paclitaxel(CAS DataBase Reference)
• NIST Chemistry Reference: 2'-(2,2,2-trichloroethoxycarbonyl)-7-[3-methyl-3-(2,4,6-trimethoxyphenylmethylsulfanyl)butyryl]paclitaxel(382601-29-8)
• EPA Substance Registry System: 2'-(2,2,2-trichloroethoxycarbonyl)-7-[3-methyl-3-(2,4,6-trimethoxyphenylmethylsulfanyl)butyryl]paclitaxel(382601-29-8)

Safety Data

• Hazardous Substances Data: 382601-29-8(Hazardous Substances Data)

Upstream product

• 33069-62-4 taxol 
• 61040-78-6 2,4,6-trimethoxybenzyl alcohol 
• 59729-24-7 3-mercapto-3-methylbutanoic acid 
• 100431-55-8 2'-<<(trichloroethyl)oxy>carbonyl>taxol 
• 194596-99-1 3-Methyl-3-[(2,4,6-trimethoxyphenyl)methylthio]butanoic acid 

Downstream Products

• 382601-31-2 C₅₂H₅₉NO₁₅S 
• 382601-30-1 2'-(2,2,2-trichloroethoxycarbonyl)-7-(3-methyl-3-sulfanylbutyryl)paclitaxel 

Relevant articles and documents

Combination of Paclitaxel and Nitric Oxide as a Novel Treatment for the Reduction of Restenosis

The combination of a nitric oxide (NO) donor and a paclitaxel-NO donor conjugate coated on a vascular stent was tested in a rabbit iliac artery model of stenosis as a potential therapy for restenosis. Paclitaxel was conjugated with a NO donor at the 7-pos